- Home
- CTVA vs AFL Comparison
CTVA vs AFL Comparison
Compare CTVA & AFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTVA
- AFL
- Stock Information
- Founded
- CTVA 2018
- AFL 1955
- Country
- CTVA United States
- AFL United States
- Employees
- CTVA N/A
- AFL N/A
- Industry
- CTVA Farming/Seeds/Milling
- AFL Accident &Health Insurance
- Sector
- CTVA Consumer Staples
- AFL Finance
- Exchange
- CTVA Nasdaq
- AFL Nasdaq
- Market Cap
- CTVA 48.7B
- AFL 56.4B
- IPO Year
- CTVA N/A
- AFL N/A
- Fundamental
- Price
- CTVA $74.16
- AFL $106.89
- Analyst Decision
- CTVA Strong Buy
- AFL Hold
- Analyst Count
- CTVA 14
- AFL 13
- Target Price
- CTVA $80.43
- AFL $109.15
- AVG Volume (30 Days)
- CTVA 4.3M
- AFL 2.7M
- Earning Date
- CTVA 08-06-2025
- AFL 10-29-2025
- Dividend Yield
- CTVA 0.97%
- AFL 2.17%
- EPS Growth
- CTVA 60.76
- AFL N/A
- EPS
- CTVA 2.03
- AFL 4.43
- Revenue
- CTVA $17,177,000,000.00
- AFL $15,910,000,000.00
- Revenue This Year
- CTVA $6.25
- AFL N/A
- Revenue Next Year
- CTVA $3.44
- AFL N/A
- P/E Ratio
- CTVA $34.78
- AFL $24.12
- Revenue Growth
- CTVA 1.63
- AFL N/A
- 52 Week Low
- CTVA $53.40
- AFL $96.95
- 52 Week High
- CTVA $77.41
- AFL $115.50
- Technical
- Relative Strength Index (RSI)
- CTVA 58.12
- AFL 57.98
- Support Level
- CTVA $73.39
- AFL $105.79
- Resistance Level
- CTVA $75.16
- AFL $108.41
- Average True Range (ATR)
- CTVA 1.13
- AFL 1.33
- MACD
- CTVA 0.29
- AFL 0.08
- Stochastic Oscillator
- CTVA 76.96
- AFL 55.05
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
About AFL AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.